Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2559|309-0167|4|538-547

ISSN： 0309-0167

Source： HISTOPATHOLOGY, Vol.309-0167, Iss.4, 2015-10, pp. : 538-547

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patients

By  

HISTOPATHOLOGY, Vol. 67, Iss. 4, 2015-10 ,pp. : 538-547

John Wiley & Sons Inc

Access to resources Recommend Favorite

FOXP3 Expression Is Related to High Ki-67 Index and Poor Prognosis in Lymph Node-Positive Breast Cancer Patients

By  

Oncology, Vol. 85, Iss. 2, 2013-08 ,pp. : 128-136

Karger

Access to resources Recommend Favorite

Phosphohistone‐H3 (PHH3) is prognostic relevant in Merkel cell carcinomas but Merkel cell polyomavirus is a more powerful prognostic factor than AJCC clinical stage, PHH3, Ki‐67 or mitotic indices

By  

PATHOLOGY INTERNATIONAL, Vol. 65, Iss. 8, 2015-08 ,pp. : 404-409

John Wiley & Sons Inc

Access to resources Recommend Favorite

Correlation between Ki67 and Breast Cancer Prognosis

By  

Oncology, Vol. 84, Iss. 4, 2013-01 ,pp. : 219-225

Karger

Access to resources Recommend Favorite

The clinical significance of Ki-67 as a marker of prognostic value and chemosensitivity prediction in hormone-receptor-positive breast cancer: a meta-analysis of the published literature

By Liu Yu   Yin Wenjin   Yan Tingting   Du Yueyao   Shao Zhimin   Lu Jinsong  

Current Medical Research and Opinion, Vol. 29, Iss. 11, 2013-11 ,pp. : 1453-1461

Informa Healthcare

Access to resources Recommend Favorite